top of page

Recent Posts

Pediatric Multicenter Study Shows Targeted Therapy for High-Risk Hodgkin Lymphoma Reduces Relapse

OPACC
Nov 4, 2022
1 min read

Children with high-risk Hodgkin lymphoma were 10% less likely to relapse following treatment with brentuximab vedotin combination.

Read more: https://www.roswellpark.org/newsroom/202211-pediatric-multicenter-study-shows-targeted-therapy-high-risk-hodgkin-lymphoma

Comments

Nutrition is a key ingredient for defense against infectious diseases in kids with cancer

Auditory Attention Decay Noted Post-Treatment in Pediatric Cerebellar Tumors

Cardiometabolic Considerations for Childhood Cancer Survivors Explained

Sex and Age May Influence Comorbidities in Pediatric ALL

FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer

Untreated GHD Linked to Adverse Outcomes in Childhood Cancer Survivors

Trial Shows Targeted Treatment for Childhood Brain Tumor is Safe

New approach speeds up personalized cancer treatment for young patients

Motor Deficits in Children Off Therapy for Acute Lymphoblastic Leukemia

Boys with cancer can face infertility as adults. Can storing their stem cells help?

Archive

Search By Tags

bottom of page